Chicago Equity Partners’s Impax Laboratories, Inc. IPXL Stock Holding History

Chicago Equity Partners's IPXL Position: Q2 2018 in Review

Chicago Equity Partners sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 19,290 shares — an estimated $375K sold.

Chicago Equity Partners first reported a position in IPXL in Q1 2015 and held it in 2 quarters. The position peaked at $375K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

• Chicago Equity Partners reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
• Chicago Equity Partners sold 19,290 Impax Laboratories, Inc. shares in Q2 2018, an estimated $375K.
• Chicago Equity Partners first reported a position in Impax Laboratories, Inc. in Q1 2015 and held it in 2 quarters.
• Chicago Equity Partners's Impax Laboratories, Inc. position peaked at $375K in Q1 2018.
• 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Chicago Equity Partners's 13F filing for Q2 2018, filed 10 Aug 2018.